The P/E ratio for Amphastar Pharmaceuticals stock stands at 13.17 as of Jul 25, 2024. This is calculated based on the current EPS of $3.2 and the stock price of $42.14 per share. A decrease of 34% has been recorded in the PE ratio compared to the average of 19.8 of the past four quarters.
Over the last nine years, the average PE ratio of Amphastar Pharmaceuticals has been 143.74. The current 13.17 price-to-earnings ratio is 91% less than the historical average. In the past nine years, AMPH's PE ratio reached its highest point in the Mar 2016 quarter at 1,200, with a price of $12 and an EPS of $0.01. The Mar 2020 quarter saw the lowest point at 13.37, with a price of $14.84 and an EPS of $1.11.
Maximum annual increase: 3,513.64% in 2020
Maximum annual decrease: -97.33% in 2021
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 21.7 | 45.64% |
| 2022 | 14.9 | -16.85% |
| 2021 | 17.92 | -97.33% |
| 2020 | 670.33 | 3,513.64% |
| 2019 | 18.55 | N/A |
| 2018 | N/A | N/A |
| 2017 | 240.5 | 187.23% |
| 2016 | 83.73 | N/A |
| 2015 | N/A | N/A |
| 2014 | N/A | N/A |
Currently, AMPH's PE ratio is lower than the 3, 5 and 10-year averages.
When compared to its peer stock SCYX, AMPH's PE ratio is higher.
| Stock name | PE ratio | Market cap |
|---|---|---|
| SCYX Scynexis Inc | 0.99 | $79.53M |
| AMPH Amphastar Pharmaceuticals Inc | 13.27 | $2.08B |
| RGLS Regulus Therapeutics Inc | N/A | $116.2M |
| MRNS Marinus Pharmaceuticals Inc | N/A | $78.56M |
The price to earnings ratio for AMPH stock is 13.17 as of Jul 25, 2024.
The average PE ratio for AMPH stock over the past 3 years is 19.48.
The average PE ratio for AMPH stock over the past 5 years is 88.48.
The highest quarterly PE ratio in the last nine years has been 1,200 and it was in the Mar 2016 quarter.
The current price to earnings ratio of AMPH is 91% lower than the 9-year historical average.
The P/E ratio is calculated by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Jul 25, 2024), Amphastar Pharmaceuticals's stock price is $42.14. The earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $3.2. Therefore, Amphastar Pharmaceuticals's price to earnings ratio for today is 13.17. PE RATIO(13.17) = STOCK PRICE($42.14) / TTM EPS($3.2)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.